Charles Nelson Held, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2145 Green Vista Dr, Suite 112, Sparks, NV 89431 Phone: 775-781-1407 Fax: 775-359-1497 |
News Archive
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
"Most people think malnutrition is all about not having enough food or enough of the right kind of food to eat," but while "this is a big part of the story ... there are many other links in the chain," Lawrence Haddad, director of the Institute of Development Studies, writes in a BBC Magazine opinion piece.
The Procter & Gamble Company net sales grew 10 percent to $20.9 billion for the fourth quarter and five percent to $82.6 billion for fiscal 2011.
South Korean pharmaceutical company SK Biopharmaceuticals announced that the lead drug, YKP3089, from its drug development program for the treatment of refractory epilepsy, has been awarded funding from the Korea Drug Development Fund to support clinical development for the next three years.
› Verified 1 days ago